Rothwell Investment Advisors, LLC’s Medpace MEDP Stock Holding History

Rothwell Investment Advisors, LLC’s Portfolio MEDP Stock Details MEDP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$202K	Buy	+323	New	+$189K	0.11%	173

Other funds holding MEDP

Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return

Wasatch Advisors Salt Lake City, Utah $13.5B AUM 16.58% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return

Aberdeen Group Edinburgh, United Kingdom $72.4B AUM 24.61% 1-Year Est. Return

Thrivent Financial for Lutherans Minneapolis, Minnesota $61B AUM 26.92% 1-Year Est. Return

Citigroup New York $308B AUM 40.94% 1-Year Est. Return

Riverbridge Partners Minneapolis, Minnesota $3.41B AUM 6.54% 1-Year Est. Return

Boston Trust Walden Boston, Massachusetts $12.4B AUM 21.62% 1-Year Est. Return

Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return

Fisher Asset Management Camas, Washington $348B AUM 26.9% 1-Year Est. Return

Rothwell Investment Advisors, LLC's MEDP Position: Q3 2026 in Review

Rothwell Investment Advisors, LLC opened a new position in Medpace (MEDP) in Q3 2026: 323 shares worth $202K. The stake represents 0.11% of the portfolio and ranks #173 among its holdings.

369 funds tracked by Wall St. Rank hold MEDP as of Q3 2026.

Rothwell Investment Advisors, LLC held 323 shares of Medpace worth $202K as of Q3 2026.
Medpace was a new Rothwell Investment Advisors, LLC position in Q3 2026.
Medpace made up 0.11% of Rothwell Investment Advisors, LLC's portfolio in Q3 2026, its #173 holding.
369 funds tracked by Wall St. Rank held Medpace as of Q3 2026.

Based on Rothwell Investment Advisors, LLC's 13F filing for Q3 2026, filed 6 Nov 2026.